Company Filing History:
3 out of 34 
3 out of 43 
3 out of 210 
Years Active: 2017-2025
Title: **The Innovative Journey of Serge Lebecque**
Introduction
Serge Lebecque, an accomplished inventor based in Civrieux d'Azergues, France, has made significant contributions to the field of cancer research through his innovative developments in pharmaceutical compositions. With a portfolio of two patents, he stands out as a determined figure in the fight against cancer.
Latest Patents
Serge's latest patents include pivotal discoveries in benzoimidazole derivatives as anticancer agents. These derivatives act as effective anticancer drugs, facilitating the inhibition of protein/protein interactions of the MAP Kinase Erk, ultimately leading to decreased proliferation of cancer cells. Additionally, one of his innovative methods pertains to the treatment of cancer by inhibiting the MYD88/ERK MAP kinase interaction. This method outlines how to select compounds that can enhance the effect of DNA damage-inducing chemotherapy agents, which is crucial for advancing cancer treatment methodologies.
Career Highlights
Throughout his career, Serge has worked with renowned institutions such as the Centre Léon Bérard and the Hospices Civils de Lyon. His roles in these prominent organizations have allowed him to collaborate with leading scientists and contribute to groundbreaking research in oncology.
Collaborations
Serge has had the privilege of collaborating with notable co-workers like Toufic Renno and Isabelle Coste-Invernizzi. These partnerships have provided valuable insights and have been instrumental in driving the innovative processes behind his patents.
Conclusion
In summary, Serge Lebecque is a remarkable inventor whose work in the realm of anticancer agents demonstrates the profound impact of innovation in medical science. His patented methods and compounds not only enhance our understanding of cancer therapy but also pave the way for future advancements in the field.